Share Prices & Company Research

Stockbroking

Biopharma Credit

Current Price 1.00p Bid 1.00p Ask 1.01p Change 0.40%
Last Updated: 13/12/2019 21:04. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

BioPharma Credit plc is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27th March 2017. The Company aims to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Financial Highlights Year Ended 31/12/2018

Turnover
£0.00m
Operating Profit
£0.00m
Dividend Yield
707.07
Dividend Per Share
6.59
Dividend Cover
1.01
P/E Ratio
0.14

Key Personnel

Jeremy William Sillem
Non-Executive Chairman
Stephanie Marie Leouzon
Non-Executive Director
Harry Abraham Hyman
Non-Executive Director
Duncan William Allan Budge
Non-Executive Director
Colin Bond
Non-Executive Director

Stock Details

EPIC
BPCR
ISIN
GB00BDGKMY29
Shares in Issue
1,373,932,067
Market cap
£1,360.20m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
1.00p
Bid Price
1.00p
Ask Price
1.01p
Volume
3408772
Change Today
0.00p
% Change Today
0.40%
Open
1.00p
Previous Close
1.00p
Intraday High
1.01p
Intraday Low
1.00p
52 Week High
1.07p
52 Week Low
0.99p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Biopharma Credit Intra-day Chart

Biopharma Credit News

News in this section is provided by AJ Bell

BioPharma Credit makes debt investment of up to $80m in BioDelivery Sciences 29 May 2019 | 09:04

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
0.0
0.0
Investments & Other Non-Current Assets
1,008.3
569.6
Total Non-Current Assets
1,008.3
569.6
Inventory
0.0
0.0
Trade & Receivables
21.5
5.0
Cash & Receivables
363.6
350.8
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
1,393.3
925.5

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
5.5
2.9
Long Term Liabilities
7.8
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
13.3
2.9

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
1,380.0
922.6

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
13.7
9.1
Minority Interests
0.0
0.0
Retained Earnings
22.8
26.9
Share Premium Account
607.1
150.4
Other Equity
736.4
736.2
Total Equity
1,380.0
922.6

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
67.1
26.9
Cashflow Before Financing
-369.9
-387.0
Increase / Decrease in Cash
12.8
350.8

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
0.0
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
0.0
0.0
Pre-Tax Profit
100.4
100.9
Profit / Loss for the Year
0.0
0.0

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
Q3 Dividend
14 Nov 2019
17 Dec 2019
H1 Dividend
15 Aug 2019
20 Sep 2019
Q1 Dividend
23 May 2019
21 Jun 2019
Special Dividend
28 Feb 2019
29 Mar 2019
H2 Dividend
28 Feb 2019
29 Mar 2019
Q3 Dividend
01 Nov 2018
30 Nov 2018
H1 Dividend
30 Aug 2018
28 Sep 2018
Q1 Dividend
31 May 2018
29 Jun 2018
H2 Dividend
08 Mar 2018
29 Mar 2018
Q3 Dividend
14 Dec 2017
31 Jan 2018
H1 Dividend
28 Sep 2017
31 Oct 2017
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.